Retractable Technologies (RVP) Stock Price, News & Analysis

Company Overview

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

Key Stats

• Today's Range: $0.72 to $0.78
• 50-Day Range: $0.72 to $0.85
• 52-Week Range: $0.56 to $1.23
• Volume: 50,414 shs
• Average Volume: 85,814 shs
• Market Capitalization: $22.30 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RVP Stock Analysis - Frequently Asked Questions

How have RVP shares performed this year?

Retractable Technologies' stock was trading at $0.6884 at the start of the year. Since then, RVP shares have increased by 8.2% and is now trading at $0.7450.
View the best growth stocks for 2025 here.

How were Retractable Technologies' earnings last quarter?

Retractable Technologies, Inc. (NYSE:RVP) announced its quarterly earnings results on Thursday, November, 15th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $9.86 million for the quarter. Retractable Technologies had a negative net margin of 41.11% and a negative trailing twelve-month return on equity of 17.15%.

Who are Retractable Technologies' major shareholders?

Retractable Technologies' top institutional investors include Wealthfront Advisers LLC (8.46%), Renaissance Technologies LLC (1.21%), Bridgeway Capital Management LLC (0.48%) and LPL Financial LLC (0.18%). Insiders that own company stock include Thomas J Shaw, Braden Michael Leonard and Walter O Bigby Jr.
View institutional ownership trends.

How do I buy shares of Retractable Technologies?

Shares of RVP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Retractable Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Retractable Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), CrowdStrike (CRWD), Salesforce (CRM).

Company Calendar

• Last Earnings: 11/15/2018
• Today: 3/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:RVP
• CIK: 946563
• Web: www.retractable.com
• Phone: (972) 294-1010
• Fax: 972-292-3600
• Employees: 240
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.54)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-7,010,000.00
• Net Margins: -41.11%
• Pretax Margin: -19.17%
• Return on Equity: -17.15%
• Return on Assets: -9.33%

Debt

• Debt-to-Equity Ratio: 0.01
• Current Ratio: 8.57
• Quick Ratio: 5.92

Sales & Book Value

• Annual Sales: $38.27 million
• Price / Sales: 0.58
• Cash Flow: $0.02 per share
• Price / Cash Flow: 48.25
• Book Value: $3.31 per share
• Price / Book: 0.23

Miscellaneous

• Outstanding Shares: 29,937,000
• Free Float: 13,472,000
• Market Cap: $22.30 million
• Optionable: Optionable
• Beta: 2.08